Reuters logo
BRIEF-FDA acknowledges receipt of Sorrento Therapeutics Inc's NDA for Ztlido
2017年9月12日 / 上午10点23分 / 2 个月前

BRIEF-FDA acknowledges receipt of Sorrento Therapeutics Inc's NDA for Ztlido

Sept 12 (Reuters) - Sorrento Therapeutics Inc

* Fda acknowledges receipt of Sorrento Therapeutics Inc, NDA for Ztlido; PDUFA date set for February 28, 2018

* Sorrento Therapeutics Inc - ‍PDUFA goal date for completion of FDA‘S review of SCILEX NDA is set for February 28, 2018​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below